Katie  Haskins

Dr. Katie Haskins


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2016 in Science
Verified
Journal Article
Closed access
PDF file
TDThomas Delong
Thomas Delong
TWTimothy A. Wiles
Timothy A. Wiles
RBRocky L. Baker
Rocky L. Baker
BBBrenda Bradley
Brenda Bradley
GBGene Barbour
Gene Barbour
KHKatie Haskins
Katie Haskins
T cells target peptide combos: One of the enduring mysteries of autoimmunity is the identity of the specific proteins targeted by autoimmune T cells. Delong et al. used mass spectrometry to elucidate the peptide targets of autoimmune T cells isolated from a mouse model of type 1 diabetes. T cells targeted hybrid peptides formed by the covalent linking of a peptide derived from pro-insulin to other peptides derived from proteins found in pancreatic beta cells. T cells isolated from the pancreatic islets of two individuals with type 1 diabetes also recognized such hybrid peptides, suggesting that they may play an important role in driving disease. Science , this issue p. 711

7 February 2010 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BSBrian D Stadinski
Brian D Stadinski
TDThomas Delong
Thomas Delong
NRNichole Reisdorph
Nichole Reisdorph
RRRichard Reisdorph
Richard Reisdorph
RPRoger L Powell
Roger L Powell
KHKatie Haskins
Katie Haskins

15 November 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
TDThomas Delong
Thomas Delong
RBRocky L. Baker
Rocky L. Baker
JHJing He
Jing He
GBGene Barbour
Gene Barbour
BBBrenda Bradley
Brenda Bradley
KHKatie Haskins
Katie Haskins
Chromogranin A (ChgA) has been identified as the antigen target for three NOD-derived, diabetogenic CD4 T-cell clones, including the well-known BDC-2.5. These T-cell clones respond weakly to the peptide WE14, a naturally occurring proteolytic cleavage product from ChgA. We show here that WE14 can be converted into a highly antigenic T-cell epitope through treatment with the enzyme transglutaminase (TGase). The WE14 responses of three NOD-derived CD4 T-cell clones, each with different T-cell receptors (TCRs), and of T cells from BDC-2.5 TCR transgenic mice are increased after TGase conversion of the peptide. Primary CD4 T cells isolated from NOD mice also respond to high concentrations of WE14 and significantly lower concentrations of TGase-treated WE14. We hypothesize that posttranslational modification plays a critical role in the generation of T-cell epitopes in type 1 diabetes.

7 June 2019 in Diabetes
Verified
Journal Article
Closed access
PDF file
RBRocky L. Baker
Rocky L. Baker
MRMarynette Rihanek
Marynette Rihanek
AHAnita C. Hohenstein
Anita C. Hohenstein
MNMaki Nakayama
Maki Nakayama
AMAaron W Michels
Aaron W Michels
TDThomas Delong
Thomas Delong
We recently established that hybrid insulin peptides (HIPs) are present in human islets and that T cells reactive to HIPs are found in the residual islets of organ donors with type 1 diabetes (T1D). Here, we investigate whether HIP-reactive T cells are indicative of ongoing autoimmunity in patients with T1D. We used interferon-γ enzyme-linked immune absorbent spot analyses on peripheral blood mononuclear cells (PBMCs) to determine whether patients with new-onset T1D or control subjects displayed T-cell reactivity to a panel of 16 HIPs. We observed that nearly one-half of the patients responded to one or more HIPs. Responses to four HIPs were significantly elevated in patients with T1D but not in control subjects. To characterize the T cells reactive to HIPs, we used a carboxyfluorescein succinimidyl ester–based assay to clone T cells from PBMCs. We isolated six nonredundant, antigen-specific T-cell clones, most of which reacting to their target HIPs in the low nanomolar range. One T-cell clone was isolated from the same patient on two different blood draws, indicating persistence of this T-cell clone in the peripheral blood. This work suggests that HIPs are important target antigens in human subjects with T1D and may play a critical role in disease.

1 March 2017 in Journal of Autoimmunity
Verified
Journal Article
Closed access
TWTimothy A. Wiles
Timothy A. Wiles
TDThomas Delong
Thomas Delong
RBRocky L. Baker
Rocky L. Baker
BBBrenda Bradley
Brenda Bradley
GBGene Barbour
Gene Barbour
KHKatie Haskins
Katie Haskins

25 December 2018 in Journal of Proteome Research
Verified
Journal Article
Closed access
TWT. Aaron Wiles
T. Aaron Wiles
RPRoger Powell
Roger Powell
CMCole Robert Michel
Cole Robert Michel
KBK. Scott Beard
K. Scott Beard
AHAnita Hohenstein
Anita Hohenstein
TDThomas Delong
Thomas Delong